Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa B Kimball

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Lancet (London, England)|May 20, 2008
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)Craig L Leonardi, Alexa B Kimball, Kim A Papp, et al.
International Journal of Women'S Dermatology|July 9, 2020
Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativaKevin T Savage, Elena Gonzalez Brant, Monica Rosales Santillan, et al.
NEJM Evidence|February 9, 2024
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis SuppurativaAlexa B Kimball, Elena Peeva, Seth Forman, et al.
Pediatric Dermatology|December 24, 2021
Effects of swimming on facial sebum in adolescentsPeyton C Morss-Walton, Ranch Kimball, Monica Rosales Santillan, et al.
Experimental Dermatology|February 4, 2022
Yin and Yang of skin microbiota in "swimmer acne"Peyton C Morss-Walton, Jean S McGee, Monica Rosales Santillan, et al.
The British Journal of Dermatology|July 6, 2022
Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1)Andrew Blauvelt, Alexa B Kimball, Matthias Augustin, et al.
Archives of Dermatology|October 11, 2002
Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10Alexa B Kimball, Tatsuyoshi Kawamura, Krupali Tejura, et al.
The Journal of Dermatological Treatment|May 7, 2015
Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacyTeresa L Kauf, Jui-Chen Yang, Alexa B Kimball, et al.
Journal of Drugs in Dermatology : JDD|March 8, 2012
A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeksAnne Lynn S Chang, Maria Alora-Palli, Xinaida T Lima, et al.
Journal of the American Academy of Dermatology|February 5, 2025
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled studyLindsay S Ackerman, Bethanee J Schlosser, Tianyu Zhan, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Lancet (London, England)|May 20, 2008
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)Craig L Leonardi, Alexa B Kimball, Kim A Papp, et al.
International Journal of Women'S Dermatology|July 9, 2020
Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativaKevin T Savage, Elena Gonzalez Brant, Monica Rosales Santillan, et al.
NEJM Evidence|February 9, 2024
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis SuppurativaAlexa B Kimball, Elena Peeva, Seth Forman, et al.
Pediatric Dermatology|December 24, 2021
Effects of swimming on facial sebum in adolescentsPeyton C Morss-Walton, Ranch Kimball, Monica Rosales Santillan, et al.
Experimental Dermatology|February 4, 2022
Yin and Yang of skin microbiota in "swimmer acne"Peyton C Morss-Walton, Jean S McGee, Monica Rosales Santillan, et al.
The British Journal of Dermatology|July 6, 2022
Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1)Andrew Blauvelt, Alexa B Kimball, Matthias Augustin, et al.
Archives of Dermatology|October 11, 2002
Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10Alexa B Kimball, Tatsuyoshi Kawamura, Krupali Tejura, et al.
The Journal of Dermatological Treatment|May 7, 2015
Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacyTeresa L Kauf, Jui-Chen Yang, Alexa B Kimball, et al.
Journal of Drugs in Dermatology : JDD|March 8, 2012
A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeksAnne Lynn S Chang, Maria Alora-Palli, Xinaida T Lima, et al.
Journal of the American Academy of Dermatology|February 5, 2025
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled studyLindsay S Ackerman, Bethanee J Schlosser, Tianyu Zhan, et al.
Pageof 23